Schauss A G
Life Sciences Division, American Institute for Biosocial Research, Inc., Tacoma, Washington 98401.
Ren Fail. 1991;13(1):1-4. doi: 10.3109/08860229109022139.
Acute renal failure (ARF) or renal dysfunction (RD) associated with germanium-induced nephrotoxicity has been reported in 18 patients since 1982. In 2 of these cases the patients died of acute renal and cardiogenic failure. In 17 of 18 cases biopsies showed vacuolar degeneration in renal tubular epithelial cells in the absence of glomerular changes, without proteinuria or hematuria. Accumulated elemental Ge intake in 17 patients over a period of 4 to 36 months ranged between 16 and 328 g, or more than 100 to 2000 times the average estimated dietary intake of Ge for man (1.5 mg/d; range 0.40 to 3.40 mg/d). The biological half-life of Ge is 4.5 days for kidneys, the highest retention level of any organ. The mean concentration of Ge in healthy adult kidneys is 9.0 mg/kg wet weight. In 3 patients studied with Ge-induced RD or ARF, urinary Ge excretion was 9, 15, and 60 ng/mL, compared to greater than 5 ng/mL in healthy controls, and remained elevated even 12 months after discontinuing supplemental Ge intake. The mechanism for Ge-induced nephrotoxicity remains unknown, although the suspected cause is the inorganic Ge salts, such as germanium dioxide. Sufficient evidence for a role of organogermanium compounds, such as carboxyethyl germanium sesquioxide or citrate-lactate germanate, in Ge-induced nephrotoxicity remains lacking. The recent introduction of over-the-counter Ge "nutritional" supplements in some countries increases the risk of additional cases of Ge-induced nephrotoxicity, especially if appreciable levels of inorganic Ge salts are present and consumed for long periods (greater than 3 months) at levels above the average daily estimated dietary intake for Ge.(ABSTRACT TRUNCATED AT 250 WORDS)
自1982年以来,已有18例患者报告出现与锗诱导的肾毒性相关的急性肾衰竭(ARF)或肾功能障碍(RD)。其中2例患者死于急性肾衰竭和心源性衰竭。18例中的17例活检显示肾小管上皮细胞有空泡变性,无肾小球改变,无蛋白尿或血尿。17例患者在4至36个月内累积摄入的元素锗量在16至328克之间,是人类锗平均估计膳食摄入量(1.5毫克/天;范围为0.40至3.40毫克/天)的100至2000倍以上。锗在肾脏中的生物半衰期为4.5天,是所有器官中潴留水平最高的。健康成年肾脏中锗的平均浓度为9.0毫克/千克湿重。在3例研究锗诱导的RD或ARF的患者中,尿锗排泄量分别为9、15和60纳克/毫升,而健康对照者大于5纳克/毫升,即使在停止补充锗摄入12个月后仍保持升高。尽管怀疑病因是无机锗盐,如二氧化锗,但锗诱导肾毒性的机制仍不清楚。对于有机锗化合物,如羧乙基锗倍半氧化物或柠檬酸乳酸锗在锗诱导的肾毒性中的作用,仍缺乏充分证据。最近一些国家非处方锗“营养”补充剂的引入增加了锗诱导肾毒性更多病例的风险,特别是如果存在可观水平的无机锗盐并长期(大于3个月)以高于锗平均每日估计膳食摄入量的水平食用。(摘要截短于250字)